Upgrade to SI Premium - Free Trial

Equillium (EQ)

1.42 +0.04 (2.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Leerink Assumes Equillium (EQ) at Outperform October 12, 2026 7:19 AM - StreetInsider Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference October 6, 2026 4:05 PM - Globe NewsWire Piper Sandler Reiterates Overweight Rating on Equillium (EQ) October 6, 2026 2:24 AM - StreetInsider Form 8-K Equillium, Inc. For: Oct 05 October 5, 2026 5:07 PM - SEC Filing Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504 October 5, 2026 4:05 PM - Globe NewsWire Equillium Announces Poster Presentations at the 7th International AHR Conference September 29, 2026 4:05 PM - Globe NewsWire Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers September 23, 2026 8:01 AM - StreetInsider Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum September 16, 2026 8:30 AM - Globe NewsWire EQ Works and Pattison Media form one-year data partnership September 15, 2026 8:01 AM - StreetInsider EQ Works and Pattison Media Announce Strategic Partnership to Power Next-Generation Radio Audience Intelligence September 15, 2026 8:01 AM - StreetInsider Form 10-Q Equillium, Inc. For: Jun 30 August 13, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G Equillium, Inc. Filed by: Affinity Asset Advisors, LLC August 13, 2026 4:14 PM - SEC Filing Form 8-K Equillium, Inc. For: Aug 13 August 13, 2026 4:12 PM - SEC Filing Equillium, Inc. (EQ) Tops Q2 EPS by 1c August 13, 2026 4:06 PM - StreetInsider Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights August 13, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G/A Equillium, Inc. Filed by: Adage Capital Management, L.P. August 12, 2026 12:12 PM - SEC Filing Full Article List